Vimta Labs Limited is India's most comprehensive contract research and testing organization, providing services across pharmaceutical, biopharmaceutical, food, consumer goods, and many other industries.

The company reported record quarterly sales of INR 104.5 crore for Q3, representing a notable 22.3% year-on-year growth, driven primarily by pharmaceutical research and food testing services.

Vimta Labs expanded its testing infrastructure, enhancing its service capabilities in pharmaceuticals, nutraceuticals, and food testing, indicating readiness to capture emerging market opportunities.

The company completed a successful WHO audit for its clinical research division, showcasing its strong commitment to quality and compliance.

Vimta Labs is moving into biologics contract research and development, with plans to commercialize its services by Q1 FY 2027, signaling strategic growth into the biologics sector.